mochi glp 1 Investigators find contamination, untrained workers plague GLP-1 drugmaker facility in Kirkland Mochi: Pricing and Step-by-Step Guide

Among 81,617 patients with existing substance-use disorders, the odds of related emergency department visits during the next three years were 31% lower for those on GLP-1s

Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms

How do people take retatrutide

Early diagnosis and standard DKA management are key to preventing serious outcomes

Key genetic variants such as GLP1R rs6923761 and MC4R rs17782313 help predict how effectively a patient's body responds to semaglutide, information that can guide therapy selection and dosing strategy

In 2024 the Food and Drug Administration added cardiovascular risk as a reason to be prescribed the GLP-1 drug Wegovy, grounded in results from a major trial that showed fewer heart attacks, strokes, and cardiovascular deaths in adults with obesity or overweight and established heart disease